Published online 5 May 2011 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.8862
K E Y W O R D S: corpora cavernosa; corpora spongiosa; fetus; LUTO; megacystis; megalourethra; oligohydramnios; renal failure
ABSTRACT
Objective Congenital megalourethra is a rare urogenital
malformation characterized by dilation and elongation of
the penile urethra associated with absence or hypoplasia
of the corpora spongiosa and cavernosa. Postnatal
complications include voiding and erectile dysfunction
as well as renal insufficiency and pulmonary hypoplasia.
To date, only a few prenatally diagnosed cases have been
reported. We report on 10 cases diagnosed prenatally and
their postnatal/autopsy findings.
Methods The study involved retrospective chart review
of all cases diagnosed antenatally in three tertiary care
centers over 5 years. Antenatal ultrasound images and
medical records from obstetrics, genetics, urology and
nephrology were reviewed.
Results Ten fetuses with megalourethra were identified
at a median gestational age of 19 (range, 1324)
weeks and all were confirmed postnatally or at autopsy.
Three pregnancies were terminated and seven continued.
All cases presented with a distended bladder and
megalourethra and all cases had normal karyotype. Of
seven liveborn babies, one died neonatally of pulmonary
hypoplasia. All six infants alive at the time of writing had
a dysfunctional urethra and three suffered from impaired
or end-stage renal disease. Associated anomalies were
found in half of the cases.
Conclusion Congenital megalourethra is caused by
abnormal development or hypoplasia of the penile
erectile tissue, secondary to distal urethral obstruction.
When the amniotic fluid volume is normal, survival is
possible. However, all liveborn infants have voiding and
INTRODUCTION
Congenital megalourethra is a rare form of functional
obstructive uropathy caused by dysgenesis of the penile
corpora cavernosa and spongiosa which results in
extensive dilatation of the penile urethra1 . This condition
was originally classified into two variants: scaphoid and
fusiform2 . Patients with the scaphoid type were found to
have hypoplasia of the corpus spongiosum with bulging
of the ventral urethra, while patients with the fusiform
variant were found to have deficiency of both corpora
spongiosa and cavernosa with circumferential expansion
of the urethra3 . The first case of congenital megalourethra
was reported by Obrinsky4 , who also described its
association with prune belly syndrome, an association
that has been described subsequently by others5,6 . It has
been postulated that isolated megalourethra represents a
severe form of the prune belly triad caused by a common
initial insult (e.g. distal urethral obstruction) and resulting
in abdominal distention and thus decreased development
of the abdominal wall musculature7 .
Benacerraf et al.8 , in 1989, were the first to report
this condition prenatally and so far only a handful
Correspondence to: Dr D. Chitayat, Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynaecology, Mount
Sinai Hospital, 700 University Avenue, Room 3292, M5G 1Z5, Toronto, Ontario, Canada (e-mail: dchitayat@mtsinai.on.ca)
Accepted: 19 October 2010
ORIGINAL PAPER
Initially normal,
oligo at 25
weeks
Initially normal,
oligo at 22
weeks
Initially normal,
oligo at 17
weeks
Anhydramnios at
diagnosis
Initially normal,
oligo at 17
weeks
Normal
TOP at
21 weeks
LB: SVD at
39 weeks
LB: CS at
38 weeks
(previous CS),
neonatal death
LB: SVD at
39 weeks
LB: SVD at
38 weeks
TOP at
22 weeks
Normal
Normal
LB: SVD at
39 weeks
Normal
TOP at
22 weeks
LB: CS at
38 weeks (twins;
first breech)
Outcome
Normal
AFV
Normal at
3 years
Renal function
End-stage
renal disease
Postnatal/postmortem findings
Ureterostomy,
vesicostomy
Planned reductive
urethroplasty
Bilateral orchidopexy
Penile urethrostomy,
vesicostomy, orchidopexy
Vesicostomy, bilateral
pyelotomy, bilateral
orchidopexy
AFV, amniotic fluid volume; CS, Cesarean section; GA, gestational weeks at diagnosis; LB, live birth; oligo, oligohydramnios; SVD, spontaneous vaginal delivery; TOP, termination of pregnancy.
1 18 Dichorionicdiamniotic twins;
Twin A: normal anatomy;
Twin B: megacystis, dilated
urethra, bilateral hydroureter
and hydronephrosis, bilateral
clubfoot
2 24 Megacystis, dilated urethra,
bilateral clubfoot, hydroureters
and hydronephrosis
3 18 Megacystis, dilated urethra,
bilateral clubfoot, two-vessel
cord, hydroureters and
hydronephrosis
Table 1 Prenatal ultrasound findings, postnatal/autopsy findings and clinical manifestations in 10 cases of congenital megalourethra
Congenital megalourethra
679
680
METHODS
Ten cases included in this study were diagnosed over a
5-year period in three fetal medicine centers (Table 1).
Research ethics board approval was obtained. The
Amsalem et al.
initial ultrasound finding in all cases was megacystis,
and subsequent detailed fetal ultrasonography noted a
cystic structure between the fetal legs consistent with
megalourethra. Three pregnancies were terminated and
in the seven liveborn neonates a detailed examination
was carried out to confirm the antenatal findings and to
look for any additional abnormalities. Expert perinatal
autopsies were carried out on all fetuses when the
pregnancy was terminated (Cases 3, 6, 10) and in the
case of neonatal death (Case 8).
The bladder was aspirated and vesicoamniotic shunts
were inserted when oligohydramnios developed in Cases 2
and 9, which resulted in improved amniotic fluid volume
and live births.
Figure 1 Antenatal ultrasound images illustrating megalourethra diagnosed at 1324 weeks gestation. Cases 1, 2 and 5 show the penile
portion of the urethra as a cystic structure between the fetal legs. Case 3 shows the penile as well as the pelvic portion of the urethra. Case 7
shows a distended bladder and dilated urethra and Case 8 has a classic keyhole bladder.
Congenital megalourethra
RESULTS
Ten cases with congenital megalourethra were diagnosed
in the second trimester during routine detailed fetal
ultrasound. Table 1 summarizes the sonographic finding
in the 10 cases. The common genitourinary sonographic
findings in all cases were megacystis and dilated/elongated
phallus (Figure 1). All except Case 5 also had dilated
ureters and hydronephrosis. The amniotic fluid volume
was normal at the time of diagnosis in all except
Case 10 which had anhydramnios, and Cases 3, 8 and
9 subsequently developed severe oligohydramnios. The
diagnosis was confirmed in all liveborn babies by urologic
examination and retrograde urethrogram, and on autopsy
in all pregnancy terminations and the case of neonatal
death (Figures 24).
Case 3 had abnormalities involving other systems
(Table 1), consistent with a VACTERL association.
However, since megalourethra has not been reported
before in association with the VACTERL association,
it could be a new syndrome that has not been reported
previously. In all cases megalourethra seemed to be the
primary abnormality with megacystis, dilated ureters,
hydronephrosis/renal abnormalities and oligohydramnios
the result of a functional urethral obstruction. However,
the club foot noted in Cases 1, 2, 3 and 5 was not
secondary to oligohydramnios, but rather an associated
fetal malformation. To the best of our knowledge this
association has not been reported before. Anal atresia
was found in Cases 3 and 10 and has not been reported
before in association with megalourethra. All cases had
normal male karyotypes (46,XY).
The bladder was aspirated and a vesicoamniotic
shunt inserted in Cases 2 and 9 when oligohydramnios
developed in order to bypass the functional obstruction
and potentially improve both renal and lung prognosis.
This was done at 25 weeks gestation in Case 2 and at
17 weeks in Case 9.
Three couples (Cases 3, 6 and 10) elected to terminate
the pregnancy and consented for autopsy (Table 1;
Figure 2). In seven cases the pregnancies continued to
term. Six children were alive at last follow-up and
one neonate (Case 8) died from pulmonary hypoplasia
(Table 1). Three children (Cases 2, 7 and 9) have renal
dysfunction, two of whom (Cases 7 and 9) have end-stage
renal disease (Table 1).
681
DISCUSSION
Congenital megalourethra is a rare form of functional
lower urinary tract obstruction (LUTO) caused by
primary or secondary agenesis/hypoplasia of the penile
corporal tissues. Based on the findings at urethrography,
Dorairajan2 described two variants, scaphoid and
fusiform. Babies with the scaphoid type were found
to have hypoplasia of the corpus spongiosum, with
bulging of the ventral urethra. Those with the fusiform
variant were found to have a deficiency of both
corpora spongiosa and cavernosa, with circumferential
682
Amsalem et al.
Figure 4 Postnatal images of three of the six liveborn infants (Cases 1, 7, 9) and Case 8 (neonatal death), all of which clearly show
a megapenis.
Congenital megalourethra
structure in the perineal region. It is important to examine the abdominal and perineal regions carefully, as a
thin-walled distended urethra can easily be mistaken for
a loop of umbilical cord. Color Doppler is very helpful
in differentiating these two entities. As in other LUTO
cases, oligohydramnios is associated with a poorer prognosis. In our series, Cases 3, 8 and 9 were complicated by
oligohydramnios and Case 10 had anhydramnios. Cases 3
and 10 were terminated and Case 8 was delivered at term
but died in the early neonatal period due to pulmonary
hypoplasia. In Cases 8 and 9, pregnancy termination was
not an option (by national law).
Although most of our cases were diagnosed in the
second trimester of pregnancy, two cases were diagnosed
as early as 13 weeks, a finding that has been reported
elsewhere15 . The goal of early prenatal diagnosis of
this condition is to provide parents with an accurate
diagnosis and prognosis, thus allowing them to make an
informed decision regarding continuing or terminating the
pregnancy.
In most cases reported so far this urogenital abnormality was isolated. However, several cases (6/10 in our
series) had other abnormalities. Case 8 had anal atresia,
Case 3 had anal atresia, dextrocardia and a radial ray
defect and Case 10 had anal atresia and a cleft lip and
palate. Talipes was found in four cases (1, 2, 3 and 5).
Fetal bladder shunting has been used in other types
of LUTO to overcome the functional obstruction. A
comprehensive meta-analysis by Clark et al.16 reported
a trend towards an improvement in survival and renal
function in a small group of fetuses with LUTO with
the worst prognosis in those who underwent shunting. A
multicenter randomized controlled trial is under way to
evaluate the role of antenatal bladder shunting in LUTO
generally17 . In our series, two patients had vesico-amniotic
shunts inserted (Cases 2 and 9) and, at 18 months of
age, they suffered from impaired renal function and endstage renal disease, respectively. However, unlike other
causes of LUTO, patients with megalourethra also suffer
from dysfunction in urination and probably erection and
ejaculation, and all live children in our series had several
urologic procedures.
In summary, congenital megalourethra is a rare form
of LUTO that can be diagnosed on antenatal ultrasound
with a distended bladder, dilated ureters, hydronephrosis
and, in most cases, a normal amount of amniotic fluid
as well as a cystic structure in the perineum (Figure 1).
The survival of patients with megalourethra depends on
the prenatal renal damage and lung hypoplasia caused by
oligohydramnios. More than half of our cases had other
abnormalities. In isolated cases, quality of life in terms
of urination and sexual function depends on the ability
683
REFERENCES
1. Sharma AK, Shekhawat NS, Agarwal R, Upadhyay A, Mendoza WX, Harjai MM. Megalourethra: a report of four cases
and review of the literature. Pediatr Surg Int 1997; 12: 458460.
2. Dorairajan T. Defects of spongy tissue and congenital diverticula of the penile urethra. Aust N Z J Surg 1962; 32: 209214.
3. Jones EA, Freedman AL, Ehrlich RM. Megalourethra and
urethral diverticula. Urol Clin North Am 2002; 29: , 341348
vi.
4. Obrinsky W. Agenesis of abdominal muscles with associated
malformation of the genitourinary tract; a clinical syndrome.
Am J Dis Child 1949; 77: 362373.
5. Fisk NM, Dhillon HK, Ellis CE, Nicolini U, Tannirandorn Y,
Rodeck CH. Antenatal diagnosis of megalourethra in a fetus
with the prune belly syndrome. J Clin Ultrasound 1990; 18:
124128.
6. Perrotin F, Ayeva-Derman M, Lardy H, Cloarec S, Lansac J,
Body G. Prenatal diagnosis and postnatal outcome of congenital
megalourethra. Report of two cases. Fetal Diagn Ther 2001;
16: 123128.
7. Appel RA, Kaplan GW, Brock WA, Streit D. Megalourethra.
J Urol 1986; 135: 747751.
8. Benacerraf BR, Saltzman DH, Mandell J. Sonographic diagnosis of abnormal fetal genitalia. J Ultrasound Med 1989; 8:
613617.
9. Simma B, GaBner I, Brezinka C, Ellemunter H, Kreczy A.
Complete prenatal urinary tract obstruction caused by
congenital megalourethra. J Clin Ultrasound 1992; 20:
197199.
10. Sepulveda W, Berry SM, Romero R, King ME, Johnson MP,
Cotton DB. Prenatal diagnosis of congenital megalourethra.
J Ultrasound Med 1993; 12: 761766.
11. Wu MH, Wu RC, Kuo PL, Huang KE. Prenatal ultrasonographic diagnosis of congenital megalourethra. Prenat Diagn
1995; 15: 765768.
12. Sepulveda W, Elorza C, Gutierrez J, Vasquez P, Castro V.
Congenital megalourethra: outcome after prenatal diagnosis
in a series of 4 cases. J Ultrasound Med 2005; 24: 13031308.
13. Nesbit RM, Baum WC. Obstructive uropathy in childhood;
diagnosis and surgical management. J Mich State Med Soc
1955; 54: (Part 1): 10671071; passim.
14. Locke JR, Noe HN. Megalourethra: surgical technique for
correction of an unusual variant. J Urol 1987; 138: 110111.
15. Lam YH, Tang MH. Sonographic diagnosis of congenital
megalourethra at 13 weeks of gestation. Ultrasound Obstet
Gynecol 2000; 16: 585586.
16. Clark TJ, Martin WL, Divakaran TG, Whittle MJ, Kilby MD,
Khan KS. Prenatal bladder drainage in the management of
fetal lower urinary tract obstruction: a systematic review and
meta-analysis. Obstet Gynecol 2003; 102: 367382.
17. Kilby M, Khan K, Morris K, Daniels J, Gray R, Magill L, Martin B, Thompson P, Alfirevic Z, Kenny S, Bower S, Sturgiss S,
Anumba D, Mason G, Tydeman G, Soothill P, Brackley K,
Loughna P, Cameron A, Kumar S, Bullen P. PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction
randomised controlled trial. BJOG 2007; 114: 904905, e1e4.